Adapted from Saxenda® Product Monograph, 20221
OR = odds ratio.
Baseline mean body weight values: 106.3 kg (234.4 lb) for the Saxenda® group and placebo group.
50% of patients randomized
to Saxenda® (747 of 1472) and 43% treated
with placebo (322 of 738) completed their
160-week
weight assessment.
* Baseline values: mean body weight: 107.6 kg (237.2 lb) for Saxenda® vs. 108 kg (238.1 lb) for placebo. Missing data were imputed using the last observation carried forward (LOCF) when calculating percent change from baseline.
Adapted from Saxenda® Product Monograph 2022.
AE = adverse event; GI = gastrointestinal; LOCF = last observation carried forward.
References: